Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | PTAFR | P25105 | 2/20 | 0.32 |
| ▸ | BCL9 | O00512 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2944998 | 0.88 | ADRA1A (0.38) | ADRA1APTAFR | |
| SCHEMBL9817559 | 0.78 | TDP1 (0.37) | — | |
| SCHEMBL19363662 | 0.70 | — | — | |
| SCHEMBL2049251 | 0.70 | SLC6A3 (0.32) | PTAFRBCL9CTNNB1PTPN1ACHE | |
| SCHEMBL20562009 | 0.69 | GABRA1 (0.30) | — | |
| SCHEMBL17087121 | 0.64 | ACHE (0.50) | ADRA1AABCB1ACHE | |
| SCHEMBL4424922 | 0.63 | PDE10A (0.39) | — | |
| SCHEMBL724669 | 0.62 | ADRA1A (0.36) | ADRA1A | |
| SCHEMBL8213378 | 0.62 | ALDH1A1 (0.44) | PTPN1ACHE | |
| SCHEMBL20561999 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9601806-B2 | Redox shuttle additives for lithium-ion batteries | UCHICAGO ARGONNE, LLC (US) | 2017-03-21 | — | — | US | disclosed |
| US-9005822-B2 | Functional electrolyte for lithium-ion batteries | UCHICAGO ARGONNE, LLC (US) | 2015-04-14 | — | — | US | disclosed |
| US-20140255793-A1 | FUNCTIONAL ELECTROLYTE FOR LITHIUM-ION BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2014-09-11 | — | — | US | disclosed |
| US-20140234703-A1 | REDOX SHUTTLE ADDITIVES FOR LITHIUM-ION BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2014-08-21 | — | — | US | disclosed |
| WO-2013032593-A2 | REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2013-03-07 | — | — | WO | disclosed |
| US-7648801-B2 | Lithium battery with series-connected cells having a shuttle of 2,5-di-tert--butyl-1,4-dimethoxybenzene; limits the negative electrode potential to a value slightly above that of positive electrode maximum normal operating potential toprevent negative electrode from reaching a higher damaging one | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-01-19 | — | — | US | disclosed |
| US-20080266642-A1 | DURABLE ELECTROOPTIC DEVICES COMPRISING IONIC LIQUIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-10-30 | — | — | US | disclosed |
| US-20080266642-A1 | DURABLE ELECTROOPTIC DEVICES COMPRISING IONIC LIQUIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-10-30 | — | — | US | disclosed |
| EP-1756905-A2 | REDOX SHUTTLE FOR OVERDISCHARGE PROTECTION IN RECHARGEABLE LITHIUM-ION BATTERIES | 3M Innovative Properties Company (US) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005099025-A2 | REDOX SHUTTLE FOR OVERDISCHARGE PROTECTION IN RECHARGEABLE LITHIUM-ION BATTERIES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-10-20 | — | — | WO | disclosed |
| US-20050221168-A1 | Redox shuttle for overdischarge protection in rechargeable lithium-ion batteries | DAHN JEFFREY R | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140255793-A1 | FUNCTIONAL ELECTROLYTE FOR LITHIUM-ION BATTERIES | LAGE3, KCNE1, KCNB2 | ADRA1A 4788/4885ABCB1 1011/4885PTAFR 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.